| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.053 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |